Agf Investments Inc. Abbott Laboratories Transaction History

Agf Investments Inc.

$10.6 Billion
Q3 2022

A detailed history of Agf Investments Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Agf Investments Inc. holds 12,205 shares of ABT stock, worth $1.44 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

12,205

Previous 12,505 2.4%

Holding current value

$1.44 Million

Previous $1.36 Million 13.1%

% of portfolio

0.01%

Previous 0.01%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	SELL	$96.76 - $112.03 $29,028 - $33,609	-300 Reduced 2.4%	12,205 $1.18 Million
Q2 2022 Aug 12, 2022	SELL	$102.07 - $123.37 $10,207 - $12,337	-100 Reduced 0.79%	12,505 $1.36 Million
Q1 2022 May 10, 2022	SELL	$114.02 - $139.04 $1.86 Million - $2.27 Million	-16,337 Reduced 56.45%	12,605 $1.49 Million
Q4 2021 Feb 01, 2022	SELL	$115.53 - $141.46 $71,513 - $87,563	-619 Reduced 2.09%	28,942 $4.07 Million
Q3 2021 Nov 10, 2021	SELL	$116.66 - $129.06 $1.01 Million - $1.11 Million	-8,625 Reduced 22.59%	29,561 $3.49 Million
Q2 2021 Aug 10, 2021	BUY	$105.79 - $124.53 $3.54 Million - $4.16 Million	33,444 Added 705.27%	38,186 $4.43 Million
Q1 2021 May 14, 2021	SELL	$108.84 - $128.23 $38,094 - $44,880	-350 Reduced 6.87%	4,742 $568,000
Q4 2020 Feb 08, 2021	SELL	$105.0 - $114.42 $1.21 Million - $1.32 Million	-11,531 Reduced 69.37%	5,092 $558,000
Q3 2020 Nov 12, 2020	BUY	$91.64 - $111.29 $201,608 - $244,838	2,200 Added 15.25%	16,623 $1.81 Million
Q2 2020 Aug 11, 2020	BUY	$76.57 - $98.0 $555,898 - $711,480	7,260 Added 101.35%	14,423 $1.32 Million
Q1 2020 May 08, 2020	BUY	$62.82 - $91.86 $449,979 - $657,993	7,163 New	7,163 $565,000

Others Institutions Holding ABT

# of Institutions

3,185

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $207B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Agf Investments Inc., based on Form 13F filings with the SEC.

News

Stay updated on Agf Investments Inc. with notifications on news.

Account

Agf Investments Inc. Abbott Laboratories Transaction History